Finance

Beta
Lists
IRMD:NASDAQ
Iradimed Corp
95,56 USD
0,00%
(0,00) 1D
30-июн., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IRMD...
Mkt. cap
1,22 млд
Avg. vol.
151,84 миң
Volume
0,00
Dividend
0,84%
Quarterly dividend
0,20 USD
Ex-dividend date
2026-ж., 15-май
P/E ratio
52,07
52-wk high
107,90 USD
52-wk low
55,11 USD
EPS
1,84 USD
Beta
0,89
Shares outstanding
12,78 млн
No. of employees
166
Mkt. cap
1,22 млд
Avg. vol.
151,84 миң
Volume
0,00
Dividend
0,84%
Quarterly dividend
0,20 USD
Ex-dividend date
2026-ж., 15-май
P/E ratio
52,07
52-wk high
107,90 USD
52-wk low
55,11 USD
EPS
1,84 USD
Beta
0,89
Shares outstanding
12,78 млн
No. of employees
166
News stories
From sources across the web
About Iradimed Corp
CEO-
Employees166
Founded1992
HeadquartersОрландо, Флорида, Америка Кошмо Штаттары
SectorMedical device
Analyst ratings
Based on 1 analyst giving stock ratings to IRMD in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for IRMD in the last 3 months
Highest
Current 95,56 USD
116,00 USD (+21,39%)
Average
116,00 USD (+21,39%)
Lowest
116,00 USD (+21,39%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ilya Zubkov
Freedom Capital Markets
Buy
Initiated
116,00 USD
+21,4%
04/02/2026
Frank Takkinen
Lake Street
Buy
Reiterated
120,00 USD
+25,6%
02/11/2026
Kyle Bauser
Roth MKM
Buy
Reiterated
120,00 USD
+25,6%
02/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
20,41 млн
21,20 млн
22,69 млн
21,98 млн
Cost of goods sold
4,45 млн
4,71 млн
5,66 млн
5,16 млн
Cost of revenue
4,45 млн
4,71 млн
5,66 млн
5,16 млн
Research and development expenses
868,20 миң
674,36 миң
775,03 миң
956,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,30 млн
8,99 млн
9,16 млн
8,62 млн
Operating expense
9,17 млн
9,66 млн
9,94 млн
9,58 млн
Total operating expenses
13,62 млн
14,37 млн
15,60 млн
14,74 млн
Operating income
6,79 млн
6,83 млн
7,09 млн
7,24 млн
Other non operating income
539,25 миң
463,98 миң
-1,52 млн
532,00 миң
EBT including unusual items
7,33 млн
7,30 млн
7,79 млн
7,77 млн
EBT excluding unusual items
7,33 млн
7,30 млн
7,59 млн
7,77 млн
Income tax expense
1,55 млн
1,72 млн
1,35 млн
1,95 млн
Effective tax rate
21,20%
23,58%
17,31%
25,11%
Other operating expenses
-
-
-
-
Net income
5,77 млн
5,58 млн
6,44 млн
5,82 млн
Net profit margin
28,29%
26,30%
28,39%
26,47%
Earnings per share
0,49
0,47
0,54
0,49
Interest and investment income
-
-
2,01 млн
-
Interest expense
-
-
-
-
Net interest expenses
-
-
2,01 млн
-
Depreciation and amortization charges
-
-
-
-
EBITDA
7,00 млн
7,22 млн
7,47 млн
7,69 млн
Gain or loss from assets sale
1,16 миң
32,99 миң
2,85 миң
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more